These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 934216)

  • 21. [Current status of the preparation and use of antihemophilic fractions in France. (Their use in surgery in hemophilia)].
    Ménaché D; Josso F; Steinbuch M; Soulier JP
    Transfusion (Paris); 1966; 9(3):237-44. PubMed ID: 5969559
    [No Abstract]   [Full Text] [Related]  

  • 22. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K
    Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemofil and other factor VIII concentrates.
    Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter: Use of cryoprecipitate.
    Inwood MJ
    N Engl J Med; 1976 Jul; 295(1):51. PubMed ID: 1272293
    [No Abstract]   [Full Text] [Related]  

  • 25. Factor VIII inhibitor and severity of hemophilia.
    Schoppmann A; Waytes AT
    Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant factor VIII in hemophilia.
    Cohen A; Butler R
    N Engl J Med; 1991 May; 324(21):1515-6. PubMed ID: 1902552
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of fraction I for oral surgical procedures in patients with classic hemophilia: report of seven cases.
    Marder VJ; Gamble JW; Shulman NR
    J Oral Surg; 1966 Nov; 24(6):487-99. PubMed ID: 5296941
    [No Abstract]   [Full Text] [Related]  

  • 28. Factor VIII deficiency diseases: an approach to laboratory diagnosis and management.
    Bhargava M
    Indian Pediatr; 1981 Nov; 18(11):787-91. PubMed ID: 6804381
    [No Abstract]   [Full Text] [Related]  

  • 29. [Inhibitors suppression in hemophilia A with continued treatment of factor VIII].
    Aznar JA; Jiménez C; García I; Martín G; Borrego D; Peiro A; Marty ML
    Sangre (Barc); 1982; 27(4A):572. PubMed ID: 6818701
    [No Abstract]   [Full Text] [Related]  

  • 30. Letter: Use and misuse of cryoprecipitate.
    Hensley MJ
    N Engl J Med; 1975 Jun; 292(24):1299. PubMed ID: 1128599
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemostasis. II. The use of factor VIII concentrates in the therapy of hemophilia.
    Davis RB
    Nebr State Med J; 1971 Jun; 56(6):219-24. PubMed ID: 4253029
    [No Abstract]   [Full Text] [Related]  

  • 32. [Side-effects of factor VIII substitution in patients with hemophilia A (author's transl)].
    Tilsner V; Reuter H
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):553-7. PubMed ID: 6808385
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diffusion of hepatitis B virus (HBV) in chronic poly-transfused subjects].
    Longo G; Raimondo G; De Pasquale R; Musso R; Zappia P
    Riv Emoter Immunoematol; 1983; 30(3):321-5. PubMed ID: 6669881
    [No Abstract]   [Full Text] [Related]  

  • 34. Substitution treatment of hemophilia a and b.
    Duckert F
    Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [When native arteriovenous fistula is not possible: the permanent catheter is better].
    Coli' L; Cuna V; Capelli I; Kwin C; Donati G; La Manna G; Stefoni S
    G Ital Nefrol; 2009; 26(2):154-7. PubMed ID: 19382070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple dental extractions in patients with severe hemophilia.
    Rayne J
    J Oral Surg; 1968 Jun; 26(6):381-6. PubMed ID: 5239445
    [No Abstract]   [Full Text] [Related]  

  • 37. Lower doses of factor VIII for hemophilia.
    Penner JA; Kelly PE
    N Engl J Med; 1977 Aug; 297(7):401. PubMed ID: 876340
    [No Abstract]   [Full Text] [Related]  

  • 38. Insertion of a central venous catheter for long-term venous access in a child with severe hemophilia and recurrent intracranial hemorrhage.
    Miser AW; Roach JE; Harmel RP; Sayers MP; Miser JS
    Clin Pediatr (Phila); 1984 Oct; 23(10):589. PubMed ID: 6432396
    [No Abstract]   [Full Text] [Related]  

  • 39. Porcine factor VIII therapy in patients with congenital hemophilia and inhibitors: efficacy, patient selection, and side effects.
    Hay CR; Lozier JN; Lee CA; Lafan M; Tradati H; Santagostino E; Ciavarella N; Schiavoni M; Fukui H; Yoshioka A
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):20-5. PubMed ID: 7939768
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A].
    Kunst VA; Nováková IR; Haanen C
    Ned Tijdschr Geneeskd; 1989 Jun; 133(23):1163-6. PubMed ID: 2501689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.